Epidemiology and Acute Oral Effects Electronic Cigarette
1 other identifier
interventional
14
0 countries
N/A
Brief Summary
Electronic cigarettes are battery-powered vaporizers which have a similar feel to tobacco smoking. They do not produce cigarette smoke but rather an aerosol, which is frequently referred to as vapor. E-cigarettes are marketed as less harmful alternatives to smoking. Use and awareness of these devices has grown exponentially in recent years, with millions of people currently using them. The benefits and risks of electronic cigarette use are uncertain. There is no research on the acute oral effects of electronic cigarette in the scientific literature and no hungarian epidemiological survey has been performed in this topic. Regulation of electronic cigarettes varies across countries in the European Union, ranging from no regulation to banning them entirely. The investigators research could help to integrate the regulation of this device in Hungary and in the EU as well. The measurement of acute oral effects of e-cigarette and a hungarian epidemiological survey would be novel in this topic.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2015
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2015
CompletedFirst Submitted
Initial submission to the registry
January 4, 2017
CompletedFirst Posted
Study publicly available on registry
January 5, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 22, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 22, 2023
CompletedNovember 29, 2023
July 1, 2022
8.2 years
January 4, 2017
November 23, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in blood flow after vaping/smoking
The blood flow changes are measured by Laser Speckle Contrast Analyzer (LASCA) before (baseline) and after vaping/smoking.
baseline, immediately after smoking/vaping, and 15 minutes after smoking/vaping
Study Arms (4)
E-cigarette with nicotine
EXPERIMENTALNicotine level: 6 mg/ml
E-cigarette without nicotine
EXPERIMENTALNicotine level: 0 mg/ml
Conventional cigarette
EXPERIMENTALNicotine content: 0,5mg
Cigarette tip
PLACEBO COMPARATORPlacebo device
Interventions
An electronic cigarette or e-cigarette is a handheld electronic device that vaporizes a flavored liquid. The user inhales the vapor. The fluid in the e-cigarette, called e-liquid, is usually made of nicotine, propylene glycol, glycerine, and flavorings.
Conventional cigarette
Eligibility Criteria
You may qualify if:
- age: 19-49 years
- signed consent form
- smoking regularly e-cigarette and/or conventional cigarette for \> half year
You may not qualify if:
- not pregnant and not planning pregnancy in the next 6 month
- BMI index \< 30
- no severe parodontal disease
- no acute illness in the last 2 weeks
- no chronic disease (eg.: diabetes)
- no diet which can influence the oral pH
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 4, 2017
First Posted
January 5, 2017
Study Start
September 1, 2015
Primary Completion
November 22, 2023
Study Completion
November 22, 2023
Last Updated
November 29, 2023
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share